Answer
Yes, anaphylactic reactions have occurred during and/or shortly after onasemnogene abeparvovec infusion; patients should be monitored, and if a reaction occurs, the infusion should be interrupted and treatment provided as needed.
Sources for this answer
- Zolgensma 2 x 10Exp13 vector genomes/mL solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 16Document updated
Sources checked